Home » ETF » IEIH

IEIH - iShares Evolved U.S. Innovative Healthcare ETF

Stock Price: $33.00 USD 0.16 (0.48%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
After-hours: $33.01 +0.00 (0.00%) Apr 20, 8:00 PM
Assets $36.14M
NAV $32.85
Expense Ratio 0.18%
PE Ratio 20.79
Beta (5Y) 0.74
Dividend (ttm) $0.92
Dividend Yield 2.81%
Ex-Dividend Date Mar 25, 2021
1-Year Return -
Trading Day April 20
Last Price $33.00
Previous Close $32.85
Change ($) 0.16
Change (%) 0.48%
Day's Open 32.69
Day's Range 32.69 - 33.01
Day's Volume 4,278
52-Week Range 26.95 - 35.03

Fund Description

The investment seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.

Asset Class
Equity
Inception Date
Mar 21, 2018
Exchange
BATS
Ticker Symbol
IEIH
Index Tracked
MSCI USA IMI Health Care Index

Top 10 Holdings

53.95% of assets
NameSymbolWeight
Johnson & JohnsonJNJ10.25%
MerckMRK6.18%
PfizerPFE5.89%
AbbVieABBV5.84%
Eli LillyLLY5.01%
Bristol-Myers SquibbBMY4.73%
Gilead SciencesGILD4.62%
AmgenAMGN4.61%
Vertex PharmaceuticalsVRTX3.49%
Regeneron PharmaceuticalsREGN3.33%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Mar 25, 2021$0.106406Mar 31, 2021
Dec 14, 2020$0.099329Dec 18, 2020
Sep 23, 2020$0.096354Sep 29, 2020
Jun 15, 2020$0.063097Jun 19, 2020
Mar 25, 2020$0.10391Mar 31, 2020
Dec 16, 2019$0.09933Dec 20, 2019
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...

Other tickers mentioned: BBH, FHLC, IHE
1 week ago - ETF Trends

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

Other tickers mentioned: FDL, FTXH, IHE
3 weeks ago - Zacks Investment Research

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

Other tickers mentioned: DHS, FDL, FTXH, HDV
3 months ago - Zacks Investment Research

Capital gains are rare in the ETF space, but there are always some.

Other tickers mentioned: EDV, ICVT, IEFA, JNK, LQD, QUS, SPY ...
5 months ago - ETFcom

Warren Buffett took positions in Biogen and Kroger. Investors who want to follow Buffett's picking of these two value stocks can also play these ETFs as well.

Other tickers mentioned: BBH, BIIB, FTXD, FXG, IBB, KR
1 year ago - Zacks Investment Research

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

Other tickers mentioned: IHE, IYH, VHT, XLV
1 year ago - Zacks Investment Research

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

Other tickers mentioned: BBH, IBB, PBE, PJP
1 year ago - Zacks Investment Research

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

Other tickers mentioned: IHE, IYH, VHT, XLV
1 year ago - Zacks Investment Research